✦ LIBER ✦

Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature

✍ Scribed by Raj Kumar Shrimali; Peter Denzil Correa; Nick S. Reed

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 141 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9509-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Idiopathic hyperammonemia (IHA) after do

Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature

✍ Klaus H. Metzeler; Stefan Boeck; Birgit Christ; Andreas Hausmann; Hans-Joachim S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature 1. Case report

Paclitaxel and cisplatin chemotherapy fo

Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature

✍ Krystyna Serkies; Ewa Węgrzynowicz; Jacek Jassem 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 221 KB

High dose chemotherapy with stem-cell tr

High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature

✍ Paul H. Cottu; Sylvie Giacchetti; Laurent Mignot; Bernard Epardeau; Bernard Viso 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 434 KB

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer: Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics

✍ Adriano Paccagnella; Adolfo Favaretto; Alberto Riccardi; Marco Danova; Cristina 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 983 KB

Phase 2 study of high-dose proton therap

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

✍ Joe Y. Chang; Ritsuko Komaki; Charles Lu; Hong Y. Wen; Pamela K. Allen; Anne Tsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

Ten-year follow-up of a phase 2 study of

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer

✍ Gisele A. Sarosy; Mahrukh M. Hussain; Michael V. Seiden; Arlan F. Fuller; Najmos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: The objective of this study was to assess activity and toxicity in patients with newly diagnosed, advanced‐stage epithelial ovarian cancer (EOC) who were receiving dose‐intense paclitaxel, cyclophosphamide, cisplatin, and filgrastim delivered with a flexible dosing sched